Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies
A.S. Serras, Joana S. Rodrigues, Madalena Cipriano, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

The evolving role of investigative toxicology in the pharmaceutical industry
François Pognan, Mario Beilmann, Harrie C. M. Boonen, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 317-335
Open Access | Times Cited: 124
Current hPSC-derived liver organoids for toxicity testing: Cytochrome P450 enzymes and drug metabolism
Hyemin Kim, Han‐Jin Park
Toxicological Research (2025) Vol. 41, Iss. 2, pp. 105-121
Closed Access | Times Cited: 1
Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]
José C. Fernández-Checa, Pierre Bagnaninchi, Hui Ye, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 935-959
Open Access | Times Cited: 91
Mimicking Native Liver Lobule Microarchitecture In Vitro with Parenchymal and Non-parenchymal Cells Using 3D Bioprinting for Drug Toxicity and Drug Screening Applications
G. Janani, Smriti Priya, Souradeep Dey, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 8, pp. 10167-10186
Closed Access | Times Cited: 60
Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives
Sonia Youhanna, Aurino M. Kemas, Lena C. Preiss, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 141-206
Open Access | Times Cited: 39
Liver three-dimensional cellular models for high-throughput chemical testing
Shu Yang, Masato Ooka, Ryan Jared Margolis, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 3, pp. 100432-100432
Open Access | Times Cited: 37
A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications
Renjian Xie, Vaibhav Pal, Yanrong Yu, et al.
Biomaterials (2023) Vol. 304, pp. 122408-122408
Closed Access | Times Cited: 23
3D bioprinting of liver models: A systematic scoping review of methods, bioinks, and reporting quality
Ahmed S. M. Ali, Dongwei Wu, Alexandra Bannach‐Brown, et al.
Materials Today Bio (2024) Vol. 26, pp. 100991-100991
Open Access | Times Cited: 9
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Antonio Segovia‐Zafra, Daniel E. Di Zeo-Sánchez, Carlos Lopez‐Gómez, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 12, pp. 3685-3726
Open Access | Times Cited: 44
Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow
A. Middleton, Joe Reynolds, S. Cable, et al.
Toxicological Sciences (2022) Vol. 189, Iss. 1, pp. 124-147
Open Access | Times Cited: 35
Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics
Tanvi Shroff, Kehinde Aina, Christian Maaß, et al.
Open Biology (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 31
A vision for safer food contact materials: Public health concerns as drivers for improved testing
Jane Muncke, Anna‐Maria Andersson, Thomas Backhaus, et al.
Environment International (2023) Vol. 180, pp. 108161-108161
Open Access | Times Cited: 20
Recent advances in liver‐on‐chips: Design, fabrication, and applications
Linjie Qiu, Bin Kong, Tiantian Kong, et al.
Smart Medicine (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 18
Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights
Milos Mihajlovic, Zenzi Rosseel, Elisabeth De Waele, et al.
Toxicological Sciences (2024) Vol. 199, Iss. 1, pp. 1-11
Open Access | Times Cited: 6
Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network
Antonio Segovia-Zafra, Marina Villanueva-Paz, A.S. Serras, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 4, pp. 630-640
Open Access | Times Cited: 5
Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing
Manon Bouwmeester, Yu Tao, Susana Proença, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 621-621
Open Access | Times Cited: 14
Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
Limei Li, Qingce Zang, Xinzhu Li, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 5, pp. 483-493
Open Access | Times Cited: 14
Bile acid metabolism in type 2 diabetes mellitus
Marti Cadena Sandoval, Rebecca A. Haeusler
Nature Reviews Endocrinology (2025)
Closed Access
Exploring Antimycobacterial Potential: Safety Evaluation and Active Compound Isolation from Gymnopilus junonius
Jenske Didloff, Gerhardt J. Boukes, Mutenta N. Nyambe, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 179-179
Open Access
Evaluation of toxicity, local biocompatibility, biodegradation, and systemic metabolism of cellulose/alginate/strontium apatite membranes implanted subcutaneously in mice
Juliana Dantas da Costa, Edson Araújo, J Videira e Castro, et al.
Acta Cirúrgica Brasileira (2025) Vol. 40
Open Access
In vitro liver models for toxicological research
Ichiro Fukunaga, Takanori Takebe
Drug Metabolism and Pharmacokinetics (2025), pp. 101478-101478
Closed Access
Multicellular, fluid flow-inclusive hepatic in vitro models using NANOSTACKS TM : human-relevant models for drug response prediction
Abdullah Talari, Raffaello Sbordoni, Valmira Hoti, et al.
Research Square (Research Square) (2025)
Closed Access
Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery
Tine Tricot, Catherine M. Verfaillie, Manoj Kumar
Cells (2022) Vol. 11, Iss. 3, pp. 442-442
Open Access | Times Cited: 21
2D and 3D liver models
Sarah Saxton, Kelly R. Stevens
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. 873-875
Open Access | Times Cited: 19
Toward better drug development: Three-dimensional bioprinting in toxicological research
Diána Szűcs, Zsolt Fekete, Melinda Guba, et al.
International Journal of Bioprinting (2023) Vol. 9, Iss. 2, pp. 663-663
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top